Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

VANTA BIOSCIENCE LTD.

NSE : NABSE : 540729ISIN CODE : INE695X01011Industry : Business SupportHouse : Private

BSE25.861.23 (+4.99 %)

PREV CLOSE ( ) 24.63

OPEN PRICE ( ) 25.86

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 20250

TODAY'S LOW / HIGH ( )25.85 25.86

52 WK LOW / HIGH ( ) 19.0856

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-04 2016

Management Info

- Chairman Dopesh Raja Mulakala - Managing Director

Registered Office

Address No.02/ G/308/ G, No.3/ F F/ S F/1-20-248 ,Umajay Complex,Rasoolpura, Secunderabad,
Hyderabad,
Telangana-500003

Phone 040-6657 5454 / 2790 3226

Email cs@vantabio.com / info@vantabio.com

Website www.vantabio.com

Registrars Details

Bigshare Services Pvt Ltd

306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad

Listing : BSE

NEWS

09May Vanta Bioscience informs about disclos
Vanta Bioscience has informed that it enclosed disclosure under Regulati..

19Sep Vanta Bioscience informs about submiss
In connection with Audited Standalone and Consolidated Financial results..

03Apr Vanta Bioscience bags order of Rs 1.2
Vanta Bioscience has received an order of Rs 1.2 crore from a large Indi..

04Dec Salasar Techno Engineering, Hero MotoC
Salasar Techno Engineering (STEL) has secured an Engineering, Procuremen..

02Dec Vanta Bioscience gets order worth Rs 5
Vanta Bioscience has received an order of Rs 57 lakh from a renowned Sin..

Financials

Rs. in Millions

	QTR	ANNUAL 25
Net Profit		-26.6
Gross Profit		-27.2
Operating Profit		-16.17
Net Sales		11.27

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

EFC (I) (BSE) 324.60 (1.55%)	M.Cap ( in Cr)3231.50
RK Swamy (BSE) 157.60 (1.51%)	M.Cap ( in Cr)795.52
Nukleus Office Solut (BSE) 162.00 (1.25%)	M.Cap ( in Cr)65.32
Starlog Enterprises (BSE) 62.97 (1.55%)	M.Cap ( in Cr)94.25
Icon Facilitators (BSE) 54.70 (0.83%)	M.Cap ( in Cr)42.99

Shareholding Pattern

	PROMOTERS	72.81%
	NON-INSTITUTION	27.19%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

VANTA BIOSCIENCE LTD.